Abstract
Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.
Original language | English |
---|---|
Journal | Current Cardiovascular Imaging Reports |
Volume | 4 |
Issue number | 2 |
Pages (from-to) | 98-107 |
Number of pages | 10 |
ISSN | 1941-9066 |
DOIs | |
Publication status | Published - 01.12.2011 |
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)